PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
News Release
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha
Articles with Puma Biotechnology
PBYI Stock Forecast, Price & News (Puma Biotechnology)
Puma Biotechnology: A Speculative Investment At A Discount (NASDAQ:PBYI) | Seeking Alpha
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
Puma Biotechnology Inc
Puma Biotechnology - Crunchbase Company Profile & Funding
PBYI Institutional Ownership and Shareholders - Puma Biotechnology Inc (NASDAQ) Stock
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | The Motley Fool
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Buy Puma Biotechnology Inc stock & View ($PBYI) Share Price on eToro.
Puma Biotech News, Puma Biotech Quote, PBYI Quote - StreetInsider.com
Video Puma Biotechnology Soars on Breast Cancer Drug Results - ABC News
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
Puma Biotechnology
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Puma Biotechnology (PBYI) Q1 Earnings: Stock To Disappoint? | Investing.com
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
